EG20275A - Calcium channel blacking polypeptides from filistato hibernalis - Google Patents

Calcium channel blacking polypeptides from filistato hibernalis

Info

Publication number: EG20275A
Authority: EG; Egypt
Prior art keywords: pct; hibernalis; calcium channel; filistato; blacking
Prior art date: 1992-05-21

Application number

EG29993A

Other languages

English (en)

Inventor

Steven D Heck

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-21

Filing date

1993-05-18

Publication date

1998-05-31

1993-05-18 Application filed by Pfizer filed Critical Pfizer

1998-05-31 Application granted granted Critical

1998-05-31 Publication of EG20275A publication Critical patent/EG20275A/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Insects & Arthropods (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EG29993A 1992-05-21 1993-05-18 Calcium channel blacking polypeptides from filistato hibernalis EG20275A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US88707392A	1992-05-21	1992-05-21

Publications (1)

Publication Number	Publication Date
EG20275A true EG20275A (en)	1998-05-31

Family

ID=25390404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG29993A EG20275A (en)	1992-05-21	1993-05-18	Calcium channel blacking polypeptides from filistato hibernalis

Country Status (26)

Country	Link
US (1)	US5804554A (el)
EP (1)	EP0672056B1 (el)
JP (1)	JP2572715B2 (el)
KR (1)	KR950701647A (el)
CN (1)	CN1034123C (el)
AT (1)	ATE155488T1 (el)
AU (1)	AU668170B2 (el)
BR (1)	BR9306388A (el)
CA (1)	CA2134889C (el)
CZ (1)	CZ284794A3 (el)
DE (1)	DE69312320T2 (el)
DK (1)	DK0672056T3 (el)
EG (1)	EG20275A (el)
ES (1)	ES2105261T3 (el)
FI (1)	FI932284A7 (el)
GR (1)	GR3024690T3 (el)
HU (1)	HUT64570A (el)
IL (1)	IL105694A (el)
MX (1)	MX9302925A (el)
MY (1)	MY108890A (el)
NO (1)	NO944417L (el)
NZ (1)	NZ252452A (el)
RU (1)	RU2106358C1 (el)
TW (1)	TW336938B (el)
WO (1)	WO1993023428A1 (el)
ZA (1)	ZA933493B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5461032A (en) *	1991-03-01	1995-10-24	Fmc Corporation	Insecticidally effective peptides
IL104419A0 (en) *	1992-01-24	1993-05-13	Fmc Corp	Insecticidally effective peptides
US5457178A (en) *	1993-07-07	1995-10-10	Fmc Corporation	Insecticidally effective spider toxin
US5756459A (en) *	1995-06-07	1998-05-26	Fmc Corporation	Insecticidally effective peptides isolatable from phidippus spider venom
CO5180581A1 (es) *	1999-09-30	2002-07-30	Pfizer Prod Inc	Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
AU2006333611B2 (en) *	2005-12-30	2012-04-26	Spiber Technologies Ab	Spider silk proteins and methods for producing spider silk proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5239059A (en) *	1991-05-10	1993-08-24	The Children's Hospital Of Philadelphia	Ion-channel forming peptides

1993
- 1993-03-13 TW TW082101869A patent/TW336938B/zh active
- 1993-04-30 BR BR9306388A patent/BR9306388A/pt not_active Application Discontinuation
- 1993-04-30 DK DK93910820.5T patent/DK0672056T3/da active
- 1993-04-30 AT AT93910820T patent/ATE155488T1/de active
- 1993-04-30 WO PCT/US1993/003921 patent/WO1993023428A1/en not_active Ceased
- 1993-04-30 CZ CZ942847A patent/CZ284794A3/cs unknown
- 1993-04-30 DE DE69312320T patent/DE69312320T2/de not_active Expired - Fee Related
- 1993-04-30 US US08/379,538 patent/US5804554A/en not_active Expired - Fee Related
- 1993-04-30 NZ NZ252452A patent/NZ252452A/en unknown
- 1993-04-30 JP JP5520246A patent/JP2572715B2/ja not_active Expired - Lifetime
- 1993-04-30 KR KR1019940704145A patent/KR950701647A/ko not_active Ceased
- 1993-04-30 CA CA002134889A patent/CA2134889C/en not_active Expired - Fee Related
- 1993-04-30 AU AU41178/93A patent/AU668170B2/en not_active Ceased
- 1993-04-30 ES ES93910820T patent/ES2105261T3/es not_active Expired - Lifetime
- 1993-04-30 RU RU94046023A patent/RU2106358C1/ru active
- 1993-04-30 EP EP93910820A patent/EP0672056B1/en not_active Expired - Lifetime
- 1993-05-13 IL IL105694A patent/IL105694A/en not_active IP Right Cessation
- 1993-05-18 MY MYPI93000914A patent/MY108890A/en unknown
- 1993-05-18 EG EG29993A patent/EG20275A/xx active
- 1993-05-19 ZA ZA933493A patent/ZA933493B/xx unknown
- 1993-05-19 MX MX9302925A patent/MX9302925A/es unknown
- 1993-05-19 FI FI932284A patent/FI932284A7/fi not_active Application Discontinuation
- 1993-05-20 CN CN93106216A patent/CN1034123C/zh not_active Expired - Fee Related
- 1993-05-20 HU HU9301476A patent/HUT64570A/hu unknown
1994
- 1994-11-18 NO NO944417A patent/NO944417L/no unknown
1997
- 1997-09-10 GR GR970402338T patent/GR3024690T3/el unknown

Also Published As

Publication number	Publication date
ATE155488T1 (de)	1997-08-15
DE69312320D1 (de)	1997-08-21
AU668170B2 (en)	1996-04-26
DK0672056T3 (da)	1997-12-08
NO944417D0 (no)	1994-11-18
MX9302925A (es)	1993-11-01
JPH07503735A (ja)	1995-04-20
CZ284794A3 (en)	1995-08-16
EP0672056B1 (en)	1997-07-16
US5804554A (en)	1998-09-08
RU2106358C1 (ru)	1998-03-10
IL105694A (en)	1998-02-22
CN1034123C (zh)	1997-02-26
HUT64570A (en)	1994-01-28
GR3024690T3 (en)	1997-12-31
KR950701647A (ko)	1995-04-28
WO1993023428A1 (en)	1993-11-25
FI932284L (fi)	1993-11-22
ZA933493B (en)	1994-11-21
JP2572715B2 (ja)	1997-01-16
NO944417L (no)	1994-11-18
FI932284A7 (fi)	1993-11-22
IL105694A0 (en)	1993-09-22
ES2105261T3 (es)	1997-10-16
TW336938B (en)	1998-07-21
HU9301476D0 (en)	1993-09-28
MY108890A (en)	1996-11-30
CA2134889A1 (en)	1993-11-25
EP0672056A1 (en)	1995-09-20
NZ252452A (en)	1996-07-26
DE69312320T2 (de)	1997-10-30
CA2134889C (en)	1998-03-31
CN1080931A (zh)	1994-01-19
FI932284A0 (fi)	1993-05-19
RU94046023A (ru)	1996-10-10
BR9306388A (pt)	1998-09-15
AU4117893A (en)	1993-12-13

Publication	Publication Date	Title
IL106424A0 (en)	1993-11-15	Calcium channel blocking polypeptide from agelenopsis aperta
FI970203A0 (fi)	1997-01-17	Pyridyylitioyhdisteet helikobakteerien torjumiseksi
ZA933493B (en)	1994-11-21	Calcium channel blocking polypeptides from filistata hibernalis.
NO991734L (no)	1999-04-13	Pyrazolinoner for behandling av potensforstyrrelser
TW272196B (el)	1996-03-11
CA2146367A1 (en)	1994-05-11	Calcium channel blocking polypeptides from heteropoda venatoria